AML Archives - Onco'Zine

Home Tags AML

A Compound Being Developed to Treat an Eye Disease may also...

Peter Hofland, Ph.D - January 2, 2019

Daiichi Sankyo Initiates Phase I Study to Evaluate the Combination Quizartinib...

Peter Hofland, Ph.D - December 20, 2018

Gilteritinib Available for Prescription in the United States for Adults with...

Peter Hofland, Ph.D - December 11, 2018

Glasdegib Approved in Newly-Diagnosed AML Patients for Whom Intensive Chemotherapy is...

Peter Hofland, Ph.D - November 24, 2018

FDA Grants Accelerated Approval for Venetoclax in Newly-Diagnosed Acute Myeloid Leukemia...

Peter Hofland, Ph.D - November 24, 2018

Anti-Leukemic Activity and Safety Data for Gilteritinib in Relapsed

Peter Hofland, Ph.D - June 23, 2017

First Patient with Untreated High-risk Acute Myeloid Leukemia Enrolled in Phase...

Editorial Team - December 26, 2012

LATEST

Lung Cancer Among the Most Likely Conditions to Harm Patients who are Misdiagnosed

Peter Hofland, Ph.D - July 12, 2019

Japan Approves Olaparib as First-Line Maintenance Therapy in BRCA-Mutated Advanced Ovarian Cancer

Peter Hofland, Ph.D - July 10, 2019

FDA Accepts Supplemental Biologics License Applications for Pembrolizumab

Peter Hofland, Ph.D - July 10, 2019

SNDX-5613 Shows Strong Tumor Growth Inhibition and Improved Survival in Preclinical Models –

Peter Hofland, Ph.D - July 10, 2019

US FDA to Review Isatuximab as a Potential Treatment for R/R Multiple Myeloma

Peter Hofland, Ph.D - July 10, 2019